Devyn Smith

Founder of Arbor Biotechnologies

Devyn Smith

Backed by

Sources

Arbor Biotechnologies Announces $73.9 Million Series C Financing to Advance Novel Gene Editing Therapeutics — 2025-03

Browse all founders · Browse investors